Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer.

Arturo AraujoLeah M CookJeremy S FrielingWinston TanJohn A CoplandManish KohliShilpa GuptaJasreman DhillonJulio Pow-SangConor C LynchDavid Basanta

Published in: Cancers (2021)

Funded by an NCI U01 (NCI) U01CA202958-01 and a Moffitt Team Science Award. CCL and DB were partly funded by an NCI PSON U01 (U01CA244101). AA was partly funded by a Department of Defense Prostate Cancer Research Program (W81XWH-15-1-0184) fellowship. LC was partly funded by a postdoctoral fellowship (PF-13-175-01-CSM) from the American Cancer Society.

Keyphrases

prostate cancer
quality improvement
radical prostatectomy
palliative care
healthcare
squamous cell carcinoma
small cell lung cancer
papillary thyroid
public health
bone mineral density
squamous cell
simultaneous determination
pain management
liver fibrosis
type iii
cell therapy
health insurance
childhood cancer